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Worldwide, the burden of musculoskeletal disorders is increasing with great variations
between-countries, which makes it difficult for policymakers to provide resources and
adequate interventions in order to provide for their appropriate management [1]. Thus,
musculoskeletal disorders remain a public health problem and their incidence and trend is
increasing for some specific conditions [2].
Indeed, nutrients and biological biomarkers play a key role in the prognosis, diag-
nosis and health status of patients suffering from musculoskeletal conditions, being the
main indicators for understanding biological processes as well as tailoring therapeutic
interventions and nutritional programs in patients with musculoskeletal disorders [3].
Thus, the purpose of this Special Issue was to provide an update on the state of the
art, through current reviews as well as new insights and interventions, about the main role
of nutrients and biomarkers in patients who suffer from musculoskeletal conditions from a
multidisciplinary point of view. According to the aim of this Special Issue, a total of six
papers summarized in Tables 1 and 2 were published between May and December, 2020, in
Nutrients.
Among these publications, three papers were reviews providing an update of vari-
ous topics including the current metabolic impact of COVID-19 pandemic confinement
secondary to diet modifications and the reduction of physical activity [4]; the influence of
nutrients for osteoporosis prevention in a specific population of patients suffering from
inflammatory bowel disease [5]; and the relationship of nutrient and metabolic status with
spinal muscular atrophy [6].
In addition, three papers were original research studies supporting key information
from a multidisciplinary approach about the effects of curcumin and resveratrol on satellite
cells as well as biomarkers for muscle regeneration process [7]; the fat rich diet effect on
acetylcholine spontaneous release produced in mice neuromuscular junctions revealing
key aspects for the relationship myofascial pain syndrome and nutrients or biomarkers [8];
and the effects of supplementation with vitamin D and L-cysteine on the biomarkers of
musculoskeletal conditions in high-fat-diet–fed mice with vitamin D deficiency [9].
The main characteristics of the reviews provided in this Special Issue are presented in
Table 1, updating the state of the art of the available scientific evidence on nutrients and
biomarkers in musculoskeletal conditions about trending topics such as the effects of the
COVID-19 pandemic, the prevention of osteoporosis related to inflammatory bowel disease,
as well as the influence of nutrients and biomarkers in spinal muscular atrophy [4–6].
Firstly, Martínez-Ferran et al. [4] provided an interesting review which detailed the key
metabolic consequences of the COVID-19 confinement, such as increased insulin resistance,
body and abdominal fat, as well as inflammatory cytokines, which are linked to metabolic
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syndrome development and the appearance of musculoskeletal disorders, among others.
The authors encouraged researchers to explore positive energy balance as a plausible
mechanism for these nutritional and musculoskeletal disorders, and suggested that the
restriction of calorie intake could prevent the COVID-19 confinement impact associated
with physical inactivity.







Martínez-Ferrán et al. [4]
Narrative review
including 66 references.
Metabolic impairment consequences of COVID-19 physical inactivity,
overweight, sedentary lifestyle, overfeeding and dietary intake
modifications may predispose to musculoskeletal disorders. The restriction
of calorie intake was proposed to prevent the COVID-19 confinement
impact on physical inactivity and musculoskeletal conditions.
June, 2020.
Ratajczak et al. [5]
Narrative review
including 134 references.
Protein, fat, carbohydrate, vitamin, mineral, microelement and polyphenol
intakes may predispose to osteoporosis and reduced bone mineral density
in patients suffering from inflammatory bowel diseases. The development
of nutritional guidelines to prevent osteoporosis for patients suffering from
inflammatory bowel diseases should especially take into account vitamin
D and calcium for bones mineral density, as well as vitamins such as A, B12,
C and K, calcium, folic acid, magnesium, phosphorus, zinc, sodium,
selenium and copper for bones mass formation.
December, 2020.
Li et al. [6]
Narrative review
including 85 references.
Lipid metabolic alterations, glucose metabolic modifications and vitamin
levels alteration may be linked to neurodegenerative diseases such as
spinal muscular atrophy. Dietary issues monitoring by biomarkers and
nutrients may determine nutritional status and therapeutic target in
patients who suffer from spinal muscular atrophy.
Secondly, Ratajczak et al. [5] reviewed the influence of nutrients in preventing osteo-
porosis and low bone mineral density in patients who suffered from inflammatory bowel
disease, i.e. ulcerative colitis and Crohn’s disease. Vitamin D and calcium were the most
commonly studied nutrients for bone mineral density. In addition, vitamins such as A,
B12, C and K, calcium, folic acid, magnesium, phosphorus, zinc, sodium, selenium and
copper were implicated in bone mass formation. These patients seemed to commonly
consume inadequate amounts of these vitamins and minerals, impairing absorption and
disturbing nutritional status with an increase in the risk of osteoporosis. Therefore, the
authors also encouraged researchers to develop nutritional guidelines for patients suffering
from inflammatory bowel diseases to prevent osteoporosis.
Lastly, the review carried out by Li et al. [6] highlighted the relationship between
nutrient and metabolic status and neurodegenerative diseases. Concretely, various fatty
acids’ metabolic alterations and glucose tolerance impairment were linked to spinal mus-
cular atrophy. Thus, nutritional support as well as monitoring of biomarkers and nutrients
may play a key role in patients who suffer from spinal muscular atrophy. Furthermore,
metabolomics may provide a promising support as therapeutic targets or specific biomark-
ers for metabolic alterations and for the quantification of specific metabolites in patients
who suffer from this neurodegenerative disease.
The principal characteristics of the original research reports published in this Special
Issue are presented in Table 2, providing new insights and interventions about the key
role of nutrients and biomarkers in patients who suffer from musculoskeletal conditions,
dealing with specific main topics such as the importance of satellite cells in the process
of muscle regeneration, the release of acetylcholine in the neuromuscular junction for
the myofascial pain syndrome development, as well as nutritional supplementation for
musculoskeletal disorders [7–9].
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Table 2. Characteristics of the original research reports included in the Special Issue about nutrients and biomarkers in
musculoskeletal diseases.




study in female mice (10
weeks old, weight ~20 g).
Pharmacological agents increased sirtuin-1 activity related to
curcumin and resveratrol enhanced muscle tissue regeneration.
Authors claimed potential clinical effects of these phenolic
compounds for muscle disuse and atrophy to improve
muscle regeneration.
October, 2020.
Gimenez-Donoso et al. [8]
Experimental laboratory
study in young (45–50 days)
adult Swiss male mice.
A fat rich diet produced acetylcholine spontaneous release in
neuromuscular junction of mice. Authors claimed that hypercaloric
diet supplementation increased spontaneous neurotransmission in
the neuromuscular junction suggesting the consequent activation of
myofascial trigger points to originate myofascial pain syndrome.
November, 2020.
Parsanathan et al. [9]
Experimental laboratory
study in male mice (5 weeks
old, 20–24 g).
Vitamin D and L-cysteine cosupplementation produced an
improvement of myogenic biomarkers of musculoskeletal conditions
and gene expression. Authors revealed that this cosupplementation
improved muscle biomarkers linked to musculoskeletal conditions
more than monotherapy.
First, Mañas-García et al. [7] carried out an excellent experimental laboratory study
detailing the curcumin and resveratrol effects on satellite cells by analyzing muscle regener-
ation biomarkers. Resveratrol and curcumin supplementation in the immobilized muscles
of mice elicited an increase in muscle satellite cells. Curcumin treatment for reloaded mus-
cles improved the cross-sectional area of hybrid muscle fibers and sirtuin-1 activity, while
resveratrol treatment for reloaded muscles improved the cross-sectional area of fast-twitch
muscle fibers, sirtuin-1 content and progenitor muscle cell count. In addition, curcumin
and resveratrol treatment for unloaded muscles improved the satellite cell number. The
authors encourage the use of curcumin and resveratrol due to their potential clinical effects
against muscle disuse and atrophy to optimize the muscle regeneration process.
Second, Gimenez-Donoso et al. [8] performed an outstanding experimental laboratory
study which supported novel findings in a prevalent musculoskeletal condition such as
myofascial pain syndrome, showing the first relationship in the research literature between
this syndrome and nutritional biomarker status due to a fat rich diet producing acetyl-
choline spontaneous release in neuromuscular junction of mice. Spontaneous acetylcholine
release at the neuromuscular junction was previously proposed as the key mechanism
activating a vicious circle which perpetuates myofascial pain syndrome as a group of motor,
sensitive and autonomic signs and symptoms originating from myofascial trigger points.
This experimental laboratory study was carried out in male Swiss mice evaluating intra-
muscular adipocytes with Sudan-III and the plaque noise of the neuromuscular junction
suggesting spontaneous acetylcholine release by electromyography. An increased plaque
noise was presented after the interruption of the proposed diets. Thus, supplementation
by a hypercaloric diet increased spontaneous neurotransmission in the neuromuscular
junction promoting the development of myofascial trigger points.
Finally, Parsanathan et al. [9] performed an experimental laboratory study in high-fat-
diet–fed mice with vitamin D deficiency, showing that vitamin D and L-cysteine cosupple-
mentation mitigated biomarkers of musculoskeletal conditions. Vitamin D and L-cysteine
cosupplementation provided beneficial effects for gene expression regarding myogenic
biomarkers. Therefore, cosupplementation of vitamin D and L-cysteine improved the skele-
tal muscle biomarkers of musculoskeletal conditions more than monotherapy in vitamin D
deficient high-fat-diet mice.
Future studies should address the role of ultrasound imaging as a promising tool
for nutrient and biomarker status in musculoskeletal disorders [10]. The analysis of
muscle tissue by sonoelastography may provide an alternative tool to indirectly evaluate
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sarcopenia and the lack of skeletal muscle mass from both qualitative and quantitative
points of view, presenting a sensitivity of 77.3%, a specificity of 100% and a diagnostic
accuracy of 87.5% [11]. The expression of mediators of neoangiogenesis and vascular
density of the synovial characteristics in patients with rheumatoid arthritis provided
a good correlation (r = 0.73) with the vascular area at histological level, linked to the
cellular profile and pro-inflammatory cytokines, which provided considerable validity for
using these measurements as objective assessments of synovial inflammation in clinical
practice [12]. In addition, ultrasound analysis of the echo-texture, echo-intensity and echo-
variation of the muscle tissue suggested promising results as biomarkers in neuromuscular
pathologies such as amyotrophic lateral sclerosis [13]. Finally, the ultrasound software for
the evaluation of muscle glycogen in the skeletal muscle may be decisive in detailing the
musculoskeletal status and risk of injury in sport performance with promising results in
this field, being a validated software with respect to muscle biopsy (r = 0.81) that allowed a
non-invasive assessment of muscle glycogen [14,15].
In conclusion, the main findings of this Special Issue summarize the current scientific
evidence available about nutrients and biomarkers in musculoskeletal diseases related to
the metabolic impairment secondary to COVID-19 confinement, the prevention of osteo-
porosis for patients suffering from inflammatory bowel diseases, and nutritional issues
in patients who suffer from spinal muscular atrophy, as well as new insights from experi-
mental animal models on pharmacological agents to enhance muscle tissue regeneration,
spontaneous acetylcholine release in the neuromuscular junction of mice by hypercaloric
diet supplementation increasing spontaneous neurotransmission and the consequent ac-
tivation of myofascial trigger points to originate myofascial pain syndrome, and the im-
provement of myogenic biomarkers of musculoskeletal conditions and gene expression
due to vitamin D and L-cysteine cosupplementation. Future studies should investigate
the role of ultrasound imaging as a promising tool for nutrient and biomarker status in
musculoskeletal disorders.
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